[1]陈宏坤,张大森.先天性巨结肠患者血清miR-223与炎性因子水平及其临床意义研究[J].临床小儿外科杂志,2021,20(04):359-364.[doi:10.12260/lcxewkzz.2021.04.011]
 Chen Hongkun,Zhang Dasen.Clinical significance of serum levels of mir-223 and inflammatory factors in children with Hirschs-prung’s disease[J].Journal of Clinical Pediatric Surgery,2021,20(04):359-364.[doi:10.12260/lcxewkzz.2021.04.011]
点击复制

先天性巨结肠患者血清miR-223与炎性因子水平及其临床意义研究

参考文献/References:

1 黄敏诗,吴江.先天性巨结肠的诊疗进展及挑战[J].赣南医报,2019,39(7):720-723,728.DOI:10.3969/j.issn.1001-5779.2019.07.019. Huang MS,Wu J.The Diagnosis and treatment progress of Hirschsprung’s disease[J].Journal of Gannan Medical University,2019,39(7):720-723,728.DOI:10.3969/j.issn.1001-5779.2019.07.019.
2 Le-Nguyen A,Righini-Grunder F,Piché N,et al.Factors influencing the incidence of Hirschsprung associated enterocolitis (HAEC)[J].J Pediatr Surg,2019,54(5):959-963.DOI:10.1016/j.jpedsurg.2019.01.026.
3 Wester,Tomas,Granstrom,et al.Mortality in Swedish patients with Hirschsprung disease[J].Pediatr Surg Int,2017,33(11):1177-1181.DOI:10.1007/s00383-017-4150-z.
4 Neudecker V,Haneklaus M,Jensen O,et al.Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome[J].J Exp Med,2017,214(6):1737-1752.DOI:10.1084/jem.20160462.
5 Wang HL,Chao K,Ng SC,et al.Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease[J].Genome Biol,2016,17(1):58.DOI:10.1186/s13059-016-0901-8.
6 Park JS,Jeong S,Han JY,et al.Endoscopic balloon dilation lithotripsy for difficult bile duct stones[J].Digest Dis Sci,2014,59(8):1898-1901.DOI:10.1007/s10620-014-3154-y.
7 Sergi C.Hirschsprung’s disease:Historical notes and pathological diagnosis on the occasion of the 100~(th) anniversary of Dr.Harald Hirschsprung’s death[J].World J Pediatr,2015,4(4):120-125.DOI:10.5409/wjcp.v4.i4.120.
8 虞贤贤.先天性巨结肠小肠结肠炎发病机制及防治研究进展[J].临床小儿外科杂志,2018,17(4):295-300.DOI:10.3969/j.issn.1671-6353.2018.04.013. Yu XX.Research advances in the pathogenesis,prevention and treatment of Hirschsprung’s disease[J].J Clin Ped Sur,2018,17(4):295-300.DOI:10.3969/j.issn.1671-6353.2018.04.013.
9 Langer JC,Rollins MD,Levitt M,et al.Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease[J].Pediatr Surg Int,2017,33(5):523-526.DOI:10.1007/s00383-017-4066-7.
10 向广俊,刘伟.先天性巨结肠相关性小肠结肠炎发病机制研究进展[J].儿科药学杂志,2019,25(5):59-62.DOI:10.13407/j.cnki.jpp.1672-108X.2019.05.019. Xiang GJ,Liu W.Process in etiology of Hirschsprung-Associated Enterocolitis[J].Journal of Pediatric Pharmacy,2019,25(5):59-62.DOI:10.13407/j.cnki.jpp.1672-108X.2019.05.019.
11 安宗剑.新生儿肠道菌群与坏死性小肠结肠炎发病关系的研究进展[J].临床小儿外科杂志,2019,18(5):356-360.DOI:10.3969/j.issn.1671-6353.2019.05.004. An ZJ.Research advances of neonatal intestinal microbiome and necrotising enterocolitis[J].J Clin Ped Sur,2019,18(5):356-360.DOI:10.3969/j.issn.1671-6353.2019.05.004.
12 胡星,王昕,邬四明.血清TNF-α、IL-6和IL-8炎症因子表达对先天性巨结肠相关性小肠结肠炎的临床意义[J].中国现代普通外科进展,2017,20(3):211-212,215.DOI:10.3969/j.issn.1009-9905.2017.03.014. Hu X,Wang X,Wu SM.Clinical significance of serum TNF-α,IL-6 and IL-8 inflammatory factors expression in Hirschsprung’s disease associated enterocolitis[J].Chinese Journal of Current Advances in General Surgery,2017,20(3):211-212,215.DOI:10.3969/j.issn.1009-9905.2017.03.014.
13 Wang J,Bai XJ,Song Q,et al.miR-223 inhibits lipid deposition and inflammation by suppressing Toll-like receptor 4 signaling in macrophages[J].Int J Mol Sci,2015,16(10):24965-24982.DOI:10.3390/ijms161024965.
14 Aziz F.The emerging role of miR-223 as novel potential diagnostic and therapeutic target for inflammatory disorders[J].Cell Immunol,2016,303:1-6.DOI:10.1016/j.cellimm.2016.04.003.
15 蒋逵葵.非编码RNA在溃疡性结肠炎活动度评估和癌变监测的应用及机理初探[D].北京协和医学院,2017.DOI:10.7666/d.Y3277488. Jiang KK.Application and mechanism of noncoding RNA in activity evaluation and cancer monitoring of ulcerative colitis[D].Peking Union Medical College,2017.DOI:10.7666/d.Y3277488.
16 Mangat R,Borthwick F,Haase T,et al.Intestinal lymphatic HDL miR-223 and ApoA-I are reduced during insulin resistance and restored with niacin[J].FASEB J,2018,32(3):1602-1612.DOI:10.1096/fj.201600298RR.
17 杨丽,周伟,尧杰,等.高通量测序技术检测新生儿坏死性小肠结肠炎患儿微小RNA的差异表达[J].中华围产医学杂志,2017,20(1):31-37.DOI:10.3760/cma.j.issn.1007-9408.2017.01.008. Yang L,Zhou W,Yao J,et al.Differential expression of microRNA in neonatal necrotizing enterocolitis based on high-throughput sequencing[J].J Perinat Med,2017,20(1):31-37.DOI:10.3760/cma.j.issn.1007-9408.2017.01.008.
18 Neudecker V,Haneklaus M,Jensen O,et al.Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome[J].J Exp Med,2017,214(6):1737-1752.DOI:10.1084/jem.201 60462.

相似文献/References:

[1]曾纪晓,徐晓钢.先天性巨结肠诊疗规范化的再思考[J].临床小儿外科杂志,2021,20(03):201.[doi:10.12260/lcxewkzz.2021.03.001]
 Zeng Jixiao,Xu Xiaogang.Some focal issues of standardizing the diagnosis and treatment of Hirschsprung’s disease[J].Journal of Clinical Pediatric Surgery,2021,20(04):201.[doi:10.12260/lcxewkzz.2021.03.001]
[2]谢华,唐维兵.规范、统一先天性巨结肠分型的建议[J].临床小儿外科杂志,2021,20(03):212.[doi:10.12260/lcxewkzz.2021.03.003]
 Xie Hua,Tang Weibing.Unifying the classification of Hirschsprung’s disease[J].Journal of Clinical Pediatric Surgery,2021,20(04):212.[doi:10.12260/lcxewkzz.2021.03.003]
[3]虞梅,葛郁荣,石静,等.超声助显剂灌肠与X线钡灌肠在先天性巨结肠诊断中的应用价值[J].临床小儿外科杂志,2021,20(03):236.[doi:10.12260/lcxewkzz.2021.03.007]
 Yu Mei,Ge Yurong,Shi Jing,et al.Ultrasound-assisted enema plus X-ray barium enema for diagnosing Hirschsprung’s disease: a retrospective study[J].Journal of Clinical Pediatric Surgery,2021,20(04):236.[doi:10.12260/lcxewkzz.2021.03.007]
[4]曾纪晓,徐晓钢,刘斐,等.经脐单孔腹腔镜辅助下Swenson-like巨结肠根治术38例[J].临床小儿外科杂志,2021,20(09):848.[doi:10.12260/lcxewkzz.2021.09.009]
 Zeng Jixiao,Xu Xiaogang,Liu Fei,et al.Efficacies of transumbilical laparoendoscopic single-port surgery for Hirschsprung disease in children,a report of 38 cases[J].Journal of Clinical Pediatric Surgery,2021,20(04):848.[doi:10.12260/lcxewkzz.2021.09.009]

备注/Memo

收稿日期:2019-12-16。
通讯作者:张大森,Email:guohong7070@qq.com

更新日期/Last Update: 1900-01-01